First Page | Document Content | |
---|---|---|
Date: 2013-05-16 09:59:52Apoptosis Autophagy Poly ADP ribose polymerase Atg1 Caspase 3 Paclitaxel Mammalian target of rapamycin Tumor hypoxia Tumor necrosis factor-alpha Biology Cell biology Programmed cell death | OPEN Citation: Cell Death and Disease[removed], e638; doi:[removed]cddis[removed] & 2013 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddisAdd to Reading ListSource URL: www.nature.comDownload Document from Source WebsiteFile Size: 2,51 MBShare Document on Facebook |
Sensitisation of glioblastoma cells to X-rays and proton in-vitro irradiation with Olaparib, a poly(ADP-ribose) polymerase inhibitor Anne-Catherine Wéra, Alexis Dimitriadis, Miriam Barry, Jonathan C. Jeynes, Michael J.DocID: 1mPF4 - View Document | |
Final results of the phase I first-in-man trial of niraparib (MK4827), a poly(ADP)ribose polymerase (PARP) inhibitor incorporating proof of concept biomarker studies and expansion cohorts involving BRCA1/2 mutation carriDocID: 1lhcT - View Document | |
Microsoft Word - BeiGene BGB 290 FPI Release_FinalDocID: 1anIY - View Document | |
Microsoft Word - ResveratrolDocID: 19OOd - View Document | |
Session.5.Discussion.Blanke.Handouts.1.SRB.pptxpptx (Read-Only)DocID: 19qmw - View Document |